Roche launches new Navify Tumour Board software

Scientific Company News

Roche has announced the launch of its new Navify Tumour Board software, which offers clinical workflow and decision support tools for clinicians providing cancer care.

The software optimises decision-making for cancer patient case reviews in tumour boards or multidisciplinary team meetings by aggregating all relevant patient data from multiple sources into one dashboard.

“Roche has launched its new Navify Tumour Board software to help optimise decision-making for cancer patient case reviews.“

This helps to facilitate efficient team collaboration, reduces errors and gives the care team more time to evaluate potential treatment options, while its cloud-based setup means it can be accessed at any time from a range of devices.

It also allows remote participation of experts from outside the location during meetings, further facilitating care team collaboration.

Navify is debuting in the US, UK, Germany, Spain, Sweden and Switzerland, having demonstrated efficiency benefits during US and EU tumour board pilot studies.

Roland Diggelmann, chief executive officer at Roche Diagnostics, said: "Oncology care teams are now able to collaborate on the review of patient cases and tailor treatments to the individual with a higher degree of confidence and more efficiently."

With over 20 years of experience within the science market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current science roles we have available, you can search for the latest job roles, register your details, or contact the team today.

See all the latest jobs in Science
Return to news